🔎 Trials Near Me

Home › Ulcerative Colitis › California › Lancaster

Ulcerative Colitis clinical trials in Lancaster, CA

8 studies for Ulcerative Colitis are looking for participants at sites in and around Lancaster (within about 30 miles). Open a study to see who can join and how to contact the study team.

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RecruitingPhase 2
  • Gastro Care Institute /ID# 281071, Lancaster
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07697456

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

RecruitingPhase 2
  • Site 012, Lancaster
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07012395

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

RecruitingPhase 2
  • Gastro Care Institute, Lancaster
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06979336

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

RecruitingPhase 3
  • Om Research LLC, Lancaster
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT07196748

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

RecruitingPhase 2
  • Om Research LLC, Lancaster
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07186101

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

RecruitingPhase 3
  • Om Research, LLC - Lancaster - Site Number: 8400148, Lancaster
Ages 16 to 80 · All sexes · Updated Aug 20, 2026 · NCT07184996

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

RecruitingPhase 2
  • Om Research, LLC, Lancaster
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT06598943

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

RecruitingPhase 2
  • Investigational Site Number: 8400006, Lancaster
Ages 18 to 75 · All sexes · Updated Apr 23, 2026 · NCT06975722

About Ulcerative Colitis

Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.

More about Ulcerative Colitis on MedlinePlus

Ulcerative Colitis trials in other cities

Other studies in Lancaster

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.